Neuronetics Income Statement (2016-2026) | STIM

Income Statement Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
14.20M13.80M15.02M14.18M16.33M16.50M18.20M15.54M17.61M17.88M20.31M17.42M16.45M18.53M22.49M31.98M38.11M37.30M41.78M34.45M
Cost of Revenue (Quarter)
2.75M9.83M-15.78M3.48M4.04M3.57M38.89M11.90M4.84M12.14M-15.96M4.33M4.27M4.53M32.50M16.24M11.87M20.19M11.74M18.30M
Gross Profit (Quarter)
11.45M10.65M11.48M10.70M12.29M12.93M13.81M11.40M12.77M11.76M15.77M13.09M12.18M14.00M14.89M15.74M17.76M17.11M21.70M16.15M
Operating items
Research & Development (Quarter)
2.29M1.57M1.74M1.80M2.04M2.35M3.14M2.79M2.36M2.15M2.21M2.35M2.23M2.42M5.77M1.62M1.80M1.50M1.67M1.36M
Selling, General & Administrative (Quarter)
6.68M6.43M6.33M6.38M6.36M6.39M6.39M6.61M6.20M6.34M6.28M5.96M6.15M7.44M10.78M13.14M12.15M11.08M13.34M13.05M
Restructuring Costs (Quarter)
8.46M8.48M
Other Operating Expenses (Quarter)
9.04M9.83M10.31M12.65M13.69M11.64M12.01M11.90M11.56M12.14M11.72M-17.90M-17.51M-22.16M-17.73M3.53M11.87M11.85M11.74M2.25M
Operating Expenses (Quarter)
18.02M17.84M18.39M20.83M22.09M20.38M21.54M21.30M20.12M20.64M20.20M19.95M20.69M21.73M26.36M26.75M25.82M24.43M26.75M25.15M
Operating Income (Quarter)
-6.56M-7.18M-6.91M-10.13M-9.80M-7.45M-7.73M-9.91M-7.35M-8.87M-4.43M-6.86M-8.51M-7.73M-11.47M-11.01M-8.06M-7.32M-5.04M-8.99M
EBIT (Quarter)
-6.56M-7.18M-6.91M-10.13M-9.80M-7.45M-7.73M-9.91M-7.35M-8.87M-4.43M-6.86M-8.51M-7.73M-11.47M-11.01M-8.06M-7.32M-5.04M-8.99M
Non-operating items
Other Non Operating Income (Quarter)
0.02M0.02M0.34M0.28M0.37M0.91M0.65M0.64M3.59M0.66M0.89M0.81M0.65M-4.40M0.55M0.25M0.19M0.13M0.15M1.02M
Non Operating Income (Quarter)
0.02M0.02M0.34M0.28M0.37M0.91M0.65M0.64M3.59M0.66M0.89M0.81M0.65M0.54M0.55M0.25M0.19M0.13M0.15M1.02M
Net income details
EBT (Quarter)
-7.54M-8.18M-7.97M-11.11M-10.60M-8.35M-8.83M-11.01M-8.49M-10.05M-6.27M-8.69M-10.48M-9.33M-13.23M-12.71M-10.03M-9.53M-7.96M-11.26M
Profit After Tax (Quarter)
-7.53M-8.15M-7.64M-10.84M-10.42M-7.61M-8.29M-10.52M-4.90M-9.39M-5.38M-7.87M-9.83M-13.34M-12.65M-12.69M-9.84M-9.04M-7.16M-10.78M
Income from Non-Controlling Interests (Quarter)
-0.01M0.28M-0.36M-0.05M0.01M
Income from Continuing Operations (Quarter)
-7.54M-8.18M-7.97M-11.11M-10.60M-8.35M-8.83M-11.01M-8.49M-10.05M-6.27M-8.69M-10.48M-9.33M-13.23M-12.71M-10.03M-9.53M-7.96M-11.26M
Consolidated Net Income (Quarter)
-7.54M-8.18M-7.97M-11.11M-10.60M-8.35M-8.83M-11.01M-8.49M-10.05M-6.27M-8.69M-10.48M-9.33M-13.23M-12.71M-10.03M-9.53M-7.96M-11.26M
Income towards Parent Company (Quarter)
-7.54M-8.18M-7.97M-11.11M-10.60M-8.35M-8.83M-11.01M-8.49M-10.05M-6.27M-8.69M-10.48M-9.33M-13.23M-12.71M-10.03M-9.53M-7.96M-11.26M
Net Income towards Common Stockholders (Quarter)
-7.54M-8.18M-7.97M-11.11M-10.60M-8.35M-8.83M-11.01M-8.49M-10.05M-6.27M-8.69M-10.48M-9.33M-13.23M-12.71M-10.03M-9.53M-7.96M-11.26M
Additional items
EPS (Basic) (Quarter)
-0.29-0.31-0.28-0.41-0.39-0.28-0.30-0.38-0.17-0.33-0.18-0.27-0.33-0.44-0.34-0.21-0.15-0.13-0.10-0.16
EPS (Weighted Average and Diluted) (Quarter)
-0.29-0.31-0.28-0.41-0.39-0.28-0.30-0.38-0.17-0.33-0.18-0.27-0.33-0.44-0.34-0.21-0.15-0.13-0.10-0.16
Shares Outstanding (Weighted Average) (Quarter)
25.90M0.07M25.48M0.07M26.79M0.07M26.90M28.03M0.06M28.50M28.66M29.47M0.02M1.15M1.73M1.73M63.84M1.95M1.95M1.95M
Shares Outstanding (Diluted Average) (Quarter)
24.61M26.30M25.48M26.60M26.69M26.96M26.90M28.03M28.32M28.50M28.66M29.47M29.76M29.93M31.73M61.47M63.84M67.31M65.95M69.59M
EBITDA (Quarter)
-6.56M-7.18M-6.91M-10.13M-9.80M-7.45M-7.73M-9.91M-7.35M-8.87M-4.43M-6.86M-8.51M-7.73M-11.47M-11.01M-8.06M-7.32M-5.04M-8.99M
Interest Expenses (Quarter)
0.98M0.99M1.06M0.98M0.80M0.90M1.10M1.10M1.14M1.18M1.84M1.83M1.98M1.60M1.76M1.70M1.97M2.21M2.92M2.27M